Back to Search
WING SZE YUNG, M.D.
M.D.
Surgery Physician
NPI: 1619102845IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
A115731(CA)
CMS Specialties
PrimaryGENERAL SURGERY
Education
LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE
Class of 2009
Research & Publications (20)
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
PMID 10944597·Br J Cancer·2000
3-trial
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
PMID 19562255·J Neurooncol·2010
3-trial
The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes.
PMID 19027283·J Nutr Biochem·2009
7-preclinical
Electrophysiological effects of neurotensin on globus pallidus neurons of 6-hydroxydopamine-lesioned rats.
PMID 19202346·Neurosignals·2009
7-preclinical
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
PMID 19293394·Neuro Oncol·2009
3-trial
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma.
PMID 19267183·J Neurooncol·2009
8-other
NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas.
PMID 19671762·Mol Cancer Ther·2009
8-other
L-DOPA neurotoxicity is mediated by up-regulation of DMT1-IRE expression.
PMID 19240805·PLoS One·2009
7-preclinical
VEGF Trap induces antiglioma effect at different stages of disease.
PMID 18708344·Neuro Oncol·2008
7-preclinical
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma.
PMID 18581057·J Neurooncol·2008
3-trial
Prevalence of post-partum thyroiditis in Liguria (Italy): an observational study.
PMID 19246971·J Endocrinol Invest·2008
8-other
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.
PMID 18559968·Neuro Oncol·2008
6-review
Exploratory analysis of the copy number alterations in glioblastoma multiforme.
PMID 19115005·PLoS One·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11175 CAMPUS STREET #21111, LOMA LINDA UNIVERSIY HEALTHCARE SYSTEM
LOMA LINDA, CA 92350 - Phone
- (909) 558-4286
Quick Facts
- NPI
- 1619102845
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile